EP1343461A1 - Use of antioxidants in means for treating halitosis - Google Patents

Use of antioxidants in means for treating halitosis

Info

Publication number
EP1343461A1
EP1343461A1 EP01989563A EP01989563A EP1343461A1 EP 1343461 A1 EP1343461 A1 EP 1343461A1 EP 01989563 A EP01989563 A EP 01989563A EP 01989563 A EP01989563 A EP 01989563A EP 1343461 A1 EP1343461 A1 EP 1343461A1
Authority
EP
European Patent Office
Prior art keywords
vitamin
antioxidants
derivatives
use according
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01989563A
Other languages
German (de)
French (fr)
Inventor
Florian Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symrise AG
Original Assignee
Symrise AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise AG filed Critical Symrise AG
Publication of EP1343461A1 publication Critical patent/EP1343461A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • JP 61286314 describes the use of
  • Vitamins for example vitamin E, vitamin B6, are known for the treatment of periodontosis, in particular for gingivitis.
  • bactericidal agents e.g. triclosan
  • flavorings menthol, menthol derivatives or mint flavors
  • the object of the present invention is accordingly to provide a means which no longer has the disadvantages described in the prior art.
  • compositions containing antioxidants or compositions containing antioxidants for the preparation of agents for eliminating oral malodor or preventing the formation of oral malodor.
  • antioxidants which are suitable or customary for oral hygiene applications can be used as antioxidants.
  • Vitamins and coenzyme are particularly suitable as antioxidants.
  • Amino acids, imidazoles, peptides, fatty acids, metal compounds and derivatives of these compounds e.g. salts, esters, ethers, sugars, nucleotides,
  • the antioxidants are preferably selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. anserine), carotenoids, caroline (e.g. ⁇ -carotene, ⁇ -carotene, lycopene) and their derivatives, lipoic acid and their derivatives (e.g.
  • amino acids eg glycine, histidine, tyrosine, tryptophan
  • imidazoles eg urocanic acid
  • peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. anserine)
  • carotenoids e.g. ⁇ -carotene
  • thiols e.g. thioredoxin, glutathione, cysteine, cystine , Cystamine and their glycosyl, N-acetyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ -linoleyl, ⁇ -linoleyl, cholesteryl, glyceryl, and Oligoglyceryl esters) and their salts,
  • fatty acids fatty acids (palmic acids), phytic acid, lactoferrin, EDTA, EGTA), ⁇ -hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, galen extracts, bilirubin, biliverdin, unsaturated fatty acids, and their derivatives (e.g. palmitoleic acid, ⁇ -linolenic acid, ⁇ -linolenic acid, linoleic acid, oleic acid), folic acid and its derivatives, ubiquinone and TJbichinol and their derivatives,
  • Vitamin C and derivatives e.g. ⁇ -scorbyl palmitate, Mg - ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. Vitamin E - acetate), vitamin A and derivatives (vitamin A - palmitate) and coniferyl benzoate of benzoin, rutinic acid and its derivatives, Ferual acid and its derivatives, butylated hydroxytoluene, butylhydroxy anisole, nordihydroguajak resin acid, nordihydroguajaretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, zinc, and its derivatives (eg ZnO, ZnSO4) selenium and its derivatives (e.g.
  • selenium methene and their derivatives (for example stilbene oxide, trans-stilbene oxide) and the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances.
  • derivatives suitable according to the invention salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids
  • Nitamm C, vitamin E, vitamin A, plastoquinone, menaquinone, ubiquinols 1-10, ubiquinones 1-10 or derivatives of these substances are particularly preferred according to the invention.
  • the amount of the antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably
  • ubiquonone and / or its derivatives and / or ubiquinol and or its derivatives are ubiquonone and / or its derivatives and / or ubiquinol and or its derivatives, vitamin C and / or its derivatives, vitamin E and / or its derivatives,
  • Vitamin A or vitamin A derivatives, or carotenes or their derivatives are used as antioxidants, the respective concentrations of which range from 0.001-10% by weight, based on the total weight of the preparation, choose.
  • the present invention is based on the principle of combating bad breath by topical application of the above-mentioned antioxidants, in particular coenzyme Q10, on the oral and pharynx mucosa by the usual means.
  • the antioxidants can accordingly be used in combination with all customary agents, in particular the customary oral care and cleansing preparations known to the person skilled in the art.
  • bactericidal agents triclosan
  • flavoring agents menthol, menthol derivatives, mint flavors
  • the use of the antioxidants mentioned leads to a noticeable reduction in bad breath odor. Examples of use include toothpastes, toothpowder and mouthwashes.
  • the use of the antioxidants can also be considered in any other means used for the treatment of the mouth and throat.
  • the active compounds according to the invention can be used particularly advantageously in opaque, translucent and transparent micro- and / or nanoemulsions. Preparations according to the invention can be particularly advantageous as
  • A-B-A triblock copolymers e.g. PEG-150 distearate, Fa.
  • star polymers e.g. PEG-300-pentaerythrityl tetrasterate or hydrophobically modified tetrakis-polyethoxylated silanes and silicones
  • the above example can also be formulated with an identical amount of retinyl palmitate, tocopheryl acetate, mannose, or lycopene instead of glyceryl alcoholate.
  • the above Example can also with an identical amount of D, L-carnosine,
  • Ascorbic acid Ascorbic acid, humic acid or coenzyme Q10 can be formulated.
  • the above example can also be formulated with an identical amount of oleic acid monoglyceride, triglycerol monolaurate or glycerol monopalmitate instead of glyceryl alcoholate.
  • Example 2 can also be formulated with an identical amount of coenzyme Q 10 retinyl palmitate, tocopheryl acetate or lycopene instead of Mg ascorbyl phosphate.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the use of antioxidants or antioxidant-containing compositions for the production of means for preventing the development of oral malodours, or for treating oral malodours.

Description

Verwendung von Antioxidantien für Mittel zur Bekämpfung von MundgeruchUse of antioxidants for bad breath control agents
Der Einsatz von Antioxidantien im Mund- und Rachenraum ist aus dem Stand der Technik grundsätzlich bekannt. So ist aus der JP 61286314 die Verwendung vonThe use of antioxidants in the mouth and throat is generally known from the prior art. JP 61286314 describes the use of
Vitaminen, beispielsweise Vitamin E, Vitamin B6 für die Behandlung von Paradontose, insbesondere gegen Gingivitis, bekannt.Vitamins, for example vitamin E, vitamin B6, are known for the treatment of periodontosis, in particular for gingivitis.
Ferner ist aus der WO 94/06418 der Einsatz des Coenzyms Q 10 für die thera- peutische Behandlung von Paradontose bekannt.Furthermore, the use of the coenzyme Q 10 for the therapeutic treatment of periodontosis is known from WO 94/06418.
Für die Bekämpfung von schlechtem Atem (oralem Malodor) werden nach dem bisherigen Stand der Technik bakterizide Mittel (z.B. Triclosan) oder Aromastoffe (Menthol, Mentholderivate oder Minzaromen) eingesetzt. Diese Mittel haben den Nachteil, dass sie nur gegen durch Bakterien verursachten schlechten Atem wirksam sind.To combat bad breath (oral malodor), bactericidal agents (e.g. triclosan) or flavorings (menthol, menthol derivatives or mint flavors) are used according to the prior art. The disadvantage of these agents is that they are only effective against bad breath caused by bacteria.
Aufgabe der vorliegenden Erfindung ist es demgemäß, ein Mittel zur Verfügung zu stellen, das die im Stand der Technik beschriebenen Nachteile nicht mehr aufweist.The object of the present invention is accordingly to provide a means which no longer has the disadvantages described in the prior art.
Diese Aufgabe wird erfindungsgemäß durch die Verwendung von Antioxidantien oder Antioxidantien enthaltenden Zusammensetzungen zur Herstellung von Mitteln zur Beseitigung von oralem Malodor oder Verhinderung der Entstehung von oralem Malodor.This object is achieved according to the invention by the use of compositions containing antioxidants or compositions containing antioxidants for the preparation of agents for eliminating oral malodor or preventing the formation of oral malodor.
Erfindungsgemäß können als Antioxidantien alle für mundhygienische Anwendungen geeigneten oder gebräuchlichen Antioxidantien verwendet werden. Insbesondere kommen Vitamine und Coenzym als Antioxidation in Betracht. Ebenso kommen z.B. Aminosäuren, Imidazole, Peptide, Fettsäuren, Metallverbindungen sowie Derivate dieser Verbindungen (z.B. Salze, Ester, Ether, Zucker, Nucleotide,According to the invention, all antioxidants which are suitable or customary for oral hygiene applications can be used as antioxidants. Vitamins and coenzyme are particularly suitable as antioxidants. Likewise, e.g. Amino acids, imidazoles, peptides, fatty acids, metal compounds and derivatives of these compounds (e.g. salts, esters, ethers, sugars, nucleotides,
Nucleoside) in Frage. Vorzugsweise werden die Antioxidantien gewählt aus der Gruppe bestehend aus Aminosäuren (z.B. Glycin, Histidin, Tyrosin, Tryptophan) und deren Derivate, Imidazole (z.B. Urocaninsäure) und deren Derivate, Peptide wie D,L-Carnosin, D- Carnosin, L-Carnosin und deren Derivate (z.B. Anserin), Carotinoide, Caroline (z.B. α-Carotin, ß-Carotin, Lycopin) und deren Derivate, Liponsäure und deren Derivate (z.B. Dihydroliponsäure), Aurothiglucose, Propylthiouracil und andere Thiole (z.B. Thioredoxin, Glutathion, Cystein, Cystin, Cystamin und deren Glycosyl-, N-Acetyl-, Ethyl-, Propyl-, Amyl-, Butyl- und Lauryl-, Palmitoyl-, Oleyl-, α-Linoleyl-, γ- Linoleyl-, Cholesteryl-, Glyceryl-, und Oligoglycerylester) sowie deren Salze,Nucleosides) in question. The antioxidants are preferably selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. anserine), carotenoids, caroline (e.g. α-carotene, β-carotene, lycopene) and their derivatives, lipoic acid and their derivatives (e.g. dihydroliponic acid), aurothiglucose, propylthiouracil and other thiols (e.g. thioredoxin, glutathione, cysteine, cystine , Cystamine and their glycosyl, N-acetyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, α-linoleyl, γ-linoleyl, cholesteryl, glyceryl, and Oligoglyceryl esters) and their salts,
Dilaurylthiodipropionat, Distearylthiodipropionat, Thiodipropionsäure und deren Derivate (Ester, Ether, Peptide, Lipide, Nukleotide, Nukleoside und Salze) sowie Sulfoximinverbindungen (z.B. Buthioninsulfoximine, Homocysteinsulfoximin, Buthioninsulfone, Penta-, Hexa-, Heptathioninsulfoximin) in sehr geringen verträg- liehen Dosierungen (z.B. pmol bis pmol/kg), ferner (Metall)-Chelatoren (z.B. α-Dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (e.g. buthioninsulfoximines, homocysteine sulfoximine, buthionine sulfones, penta-, hexa-, heptathioninsulfoximine-low dosages) pmol to pmol / kg), also (metal) chelators (e.g. α-
Hydroxyfettsäuren, Fettsäuren (Palminsäuren), Phytinsäure, Lactoferrin, EDTA, EGTA), α-Hydroxysäuren (z.B. Zitronensäure, Milchsäure, Apfelsäure), Humin- säure, Gallensäure, Galenextrakte, Bilirubin, Biliverdin, ungesättigte Fettsäuren, und deren Derivate (z.B. Palmitoleinsäure, α-Linolensäure, γ-Linolensäure, Linolsäure, Ölsäure), Folsäure und deren Derivate, Ubichinon und TJbichinol und deren Derivate,Hydroxy fatty acids, fatty acids (palmic acids), phytic acid, lactoferrin, EDTA, EGTA), α-hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, galen extracts, bilirubin, biliverdin, unsaturated fatty acids, and their derivatives (e.g. palmitoleic acid, α-linolenic acid, γ-linolenic acid, linoleic acid, oleic acid), folic acid and its derivatives, ubiquinone and TJbichinol and their derivatives,
Vitamin C und Derivate (z.B. α-Scorbylpalmitat, Mg - Ascorbylphosphat, Ascorbyl- acetat), Tocopherole und Derivate (z.B. Vitamin E - acetat), Vitamin A und Derivate (Vitamin A - palmitat) sowie Koniferylbenzoat des Benzoeharzes, Rutinsäure und deren Derivate, Ferualsäure und deren Derivate, Butylhydroxytoluol, Butylhydroxy- anisol, Nordihydroguajakharzsäure, Nordihydroguajaretsäure, Trihydroxybutyro- phenon, Harnsäure und deren Derivate, Mannose und deren Derivate, Zink, und dessen Derivate (z.B. ZnO, ZnSO4) Selen und dessen Derivate(z.B. Selenmethionin), Stilbene und deren Derivate (z.B. Stilbenoxid, Trans-Stilbenoxid) und die erfm- dungsgemäß geeigneten Derivate (Salze, Ester, Ether, Zucker, Nukleotide, Nukleoside, Peptide, und Lipide) dieser genannten Wirkstoffe. Besonders bevorzugt werden erfindungsgemäß Nitamm C, Vitamin E, Vitamin A, Plastochinon, Menachinon, Ubichinole 1-10, Ubichinone 1-10 oder Derivate dieser Stoffe.Vitamin C and derivatives (e.g. α-scorbyl palmitate, Mg - ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. Vitamin E - acetate), vitamin A and derivatives (vitamin A - palmitate) and coniferyl benzoate of benzoin, rutinic acid and its derivatives, Ferual acid and its derivatives, butylated hydroxytoluene, butylhydroxy anisole, nordihydroguajak resin acid, nordihydroguajaretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, zinc, and its derivatives (eg ZnO, ZnSO4) selenium and its derivatives (e.g. selenium methene) and their derivatives (for example stilbene oxide, trans-stilbene oxide) and the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances. Nitamm C, vitamin E, vitamin A, plastoquinone, menaquinone, ubiquinols 1-10, ubiquinones 1-10 or derivatives of these substances are particularly preferred according to the invention.
Ganz besonders bevorzugt sind die Ubichinole 1-10 und/oder deren Derivate sowieThe ubiquinols 1-10 and / or their derivatives and are also very particularly preferred
Ubichinone 1-10 sowie deren Derivate. Höchst bevorzugt ist der Einsatz von Coenzym Q10.Ubiquinones 1-10 and their derivatives. The use of coenzyme Q10 is most preferred.
Die Menge der Antioxidantien (eine oder mehrere Verbindungen) in den Zu- bereitungen beträgt vorzugsweise 0,001 bis 30 Gew.-%, besonders bevorzugtThe amount of the antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably
0,05 - 20 Gew.-%, insbesondere 1 - 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung.0.05-20% by weight, in particular 1-10% by weight, based on the total weight of the preparation.
Sofern Ubichonon und/oder dessen Derivate und/oder Ubichinol und oder dessen Derivate, Vitamin C und/oder dessen Derivate, Vitamin E und/oder dessen Derivate,If ubiquonone and / or its derivatives and / or ubiquinol and or its derivatives, vitamin C and / or its derivatives, vitamin E and / or its derivatives,
Vitamin A, bzw. Vitamin- A-Derivate, bzw. Carotine bzw. deren Derivate als Antioxidantien zum Einsatz kommen, ist vorteilhaft, deren jeweilige Konzentrationen aus dem Bereich von 0,001 - 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung, zu wählen.Vitamin A, or vitamin A derivatives, or carotenes or their derivatives are used as antioxidants, the respective concentrations of which range from 0.001-10% by weight, based on the total weight of the preparation, choose.
Die vorliegende Erfindung beruht auf dem Prinzip, Mundgeruch durch topische Applikation der oben genannten Antioxidantien, insbesondere Coenzym Q10, auf die Mund- und Rachenschleimhaut durch die üblichen Mittel, zu bekämpfen. Erfindungsgemäß können die Antioxidantien demgemäß in Kombination mit allen üblichen Mitteln insbesondere den üblichen dem Fachmann bekannten mundpflegenden und- reinigenden Zubereitungen zum Einsatz kommen. Insbesondere können neben den Antioxidantien auch bakterizide Mittel (Triclosan) und/oder Aromastoffe (Menthol, Mentholderivate, Minzaromen) eingesetzt werden. Überrascherweise führt der Einsatz der genannten Antioxidantien zu einer spürbaren Reduktion des schlechten Atemgeruchs. Beispiele für den Einsatz sind vor allen Dingen Zahncremes, Zahnpulver und Mundwässer. Ebenso kann der Einsatz der Antioxidantien aber auch in beliebigen anderen Mitteln, die zur Behandlung des Mund- und Rachenraums verwendet werden, in Betracht kommen.The present invention is based on the principle of combating bad breath by topical application of the above-mentioned antioxidants, in particular coenzyme Q10, on the oral and pharynx mucosa by the usual means. According to the invention, the antioxidants can accordingly be used in combination with all customary agents, in particular the customary oral care and cleansing preparations known to the person skilled in the art. In addition to the antioxidants, bactericidal agents (triclosan) and / or flavoring agents (menthol, menthol derivatives, mint flavors) can also be used. Surprisingly, the use of the antioxidants mentioned leads to a noticeable reduction in bad breath odor. Examples of use include toothpastes, toothpowder and mouthwashes. Likewise, the use of the antioxidants can also be considered in any other means used for the treatment of the mouth and throat.
Die erfindungsgemäßen Wirkstoffe können besonders vorteilhaft in opaken, translucenten und transparenten Mikro- und/oder Nanoemulsionen verwendet werden. Zubereitungen gemäß der Erfindung können besonders vorteilhaft alsThe active compounds according to the invention can be used particularly advantageously in opaque, translucent and transparent micro- and / or nanoemulsions. Preparations according to the invention can be particularly advantageous as
a) unverdickte,a) unthickened,
b) klassisch, z.B. durch Zusatz von Polyoxameren, Pluronics, Carragenanen oder Pflanzengummen verdickte,b) classic, e.g. thickened by adding polyoxamers, Pluronics, Carragenanen or vegetable gums,
c) durch Zusatz von A-B-A-Triblockcopolymeren (z.B. PEG-150-Distearat, Fa.c) by adding A-B-A triblock copolymers (e.g. PEG-150 distearate, Fa.
Akzo Nobel) oder alpha, omega-bis-polyethoxylierte Silane oder Silikone) verdickte,Akzo Nobel) or alpha, omega-bis-polyethoxylated silanes or silicones) thickened,
d) durch Zusatz von Sternpolymeren (z.B. PEG-300-Pentaerythrityl-tetrasterat oder hydrophob modifizierte Tetrakis-polyethoxylierte Silane und Silikone) verdickte,d) thickened by adding star polymers (e.g. PEG-300-pentaerythrityl tetrasterate or hydrophobically modified tetrakis-polyethoxylated silanes and silicones),
e) durch Zusatz von A-B-A-B-Multiblock-Copolymeren, Starburst-Polymeren, Dendrimeren und anderen supramolekularen Vernetzern (z.B. Rheodol, TWIS 399, Fa. KAO, oder PEG-120-Methylglucose-dioleat) verdickte Öl-in-e) Oil-in-thickened by adding A-B-A-B multiblock copolymers, starburst polymers, dendrimers and other supramolecular crosslinkers (e.g. Rheodol, TWIS 399, from KAO, or PEG-120-methylglucose dioleate)
Wasser- (O/W-), bikontinuierliche oder Wasser-in-Öl- (W/O-) Mikro- und/oder Nenoemulsionen Verwendung finden. BeispieleWater (O / W), bicontinuous or water-in-oil (W / O) micro and / or neno emulsions are used. Examples
Formulierungsbeispieleformulation Examples
Gel-Zahncreme mit Wirksamkeit gegen MundgeruchGel toothpaste with effectiveness against bad breath
Basis: Kieselsäure, NatriumfluoridBasis: silica, sodium fluoride
2. Zahncreme gegen Plaque mit Wirksamkeit gegen Mundgeruch 2. Toothpaste against plaque with effectiveness against bad breath
Basis: Kieselsäure, AHPBase: silica, AHP
Zahncreme gegen Plaque mit Wirksamkeit gegen MundgeruchToothpaste against plaque with effectiveness against bad breath
Basis: Kieselsäure, AlkalidiphosphatBase: silica, alkali diphosphate
4. Zahncreme gegen empfindliche Zähne mit Wirksamkeit gegen Mundgeruch4. Toothpaste for sensitive teeth with effectiveness against bad breath
Basis: Ca-carbonat, K-nitratBasis: Ca carbonate, K nitrate
5. Zahncreme gegen empfindliche Zähne mit Wirksamkeit gegen Mundgeruch 5. Toothpaste for sensitive teeth with effectiveness against bad breath
Basis: Kieselsäure, StrontiumchloridBase: silica, strontium chloride
6. Gebrauchsfertiges Mundwasser mit Fluorid und Wirksamkeit gegen Mundgeruch 6. Ready-to-use mouthwash with fluoride and effectiveness against bad breath
Basis: Ethanol, Na-fluoridBasis: ethanol, sodium fluoride
Mundwasserkonzentrat mit Wirksamkeit gegen MundgeruchMouthwash concentrate with effectiveness against bad breath
Basis: Ethanol, AromaBase: ethanol, aroma
Mundwassermouthwash
l,3-Di-(2-ethylhexyl)-cyclohexan 35,001,3-di (2-ethylhexyl) cyclohexane 35.00
Glyceryllanolat 5,00Glyceryl alcoholate 5.00
Sorbitanmonolaurat 10,00Sorbitan monolaurate 10.00
Wasser (+ Zitronensäure bis pH 5,5) 45,00Water (+ citric acid up to pH 5.5) 45.00
Das o.g. Beispiel kann auch mit einer identischen Menge an Retinylpalmitat, Tocopherylancetat, Mannose, oder Lycopin anstelle von Glyceryllanolat formuliert werden. 9. MundwasserThe above example can also be formulated with an identical amount of retinyl palmitate, tocopheryl acetate, mannose, or lycopene instead of glyceryl alcoholate. 9. Mouthwash
l,3-Di-(2-ethylhexyl)-cylcohexan 33,00 Histidin 0,501,3-di- (2-ethylhexyl) cyclohexane 33.00 histidine 0.50
Sorbitanmonolaurat 10,00Sorbitan monolaurate 10.00
Wasser (+ Zitronensäure bis pH 5,5) 45,00Water (+ citric acid up to pH 5.5) 45.00
PEG-150-Distearat 2,00PEG-150 distearate 2.00
Das o.g. Beispiel kann auch mit einer identischen Menge an D,L-Carnosin,The above Example can also with an identical amount of D, L-carnosine,
Ascorbinsäure, Huminsäure oder Coenzym Q10 formuliert werden.Ascorbic acid, humic acid or coenzyme Q10 can be formulated.
10. Rachenspülung10. Throat irrigation
Steareth-15 4,80Steareth-15 4.80
Glycerin-monostearat 2,40Glycerol monostearate 2.40
Glyceryllanolat 2,50Glyceryl alcoholate 2.50
Cyclomethicon 3,30Cyclomethicone 3.30
Cetearyloctanoat 1,70 Wasser 85,30Cetearyl octanoate 1.70 water 85.30
Das o.g. Beispiel kann auch mit einer identischen Menge an Ölsäure- monoglycerid, Triglycerinmonolaurat oder Glycerinmonopalmitat anstelle von Glyceryllanolat formuliert werden. 1. RachenspülungThe above example can also be formulated with an identical amount of oleic acid monoglyceride, triglycerol monolaurate or glycerol monopalmitate instead of glyceryl alcoholate. 1. Throat irrigation
Steareth-15 4,80Steareth-15 4.80
Mg-ascorbylphosphat 0,20Mg ascorbyl phosphate 0.20
Cholesteryl Hydroxystearat 2,50Cholesteryl hydroxystearate 2.50
Cyclomethicon 3,30Cyclomethicone 3.30
Cetearyloctanoat 17,00Cetearyl octanoate 17.00
Wasser 83,30Water 83.30
PEG-150-Distearat 2,00PEG-150 distearate 2.00
Das o.g. Beispiel kann auch mit einer identischen Menge an Coenzym Q 10 Retinylpalmitat, Tocopherylacetat oder Lycopin anstelle von Mg-ascorbylphosphat formuliert werden. The above Example can also be formulated with an identical amount of coenzyme Q 10 retinyl palmitate, tocopheryl acetate or lycopene instead of Mg ascorbyl phosphate.

Claims

Patentansprtiche Patentansprtiche
1. Verwendung von Antioxydantien oder Antioxidantien enthaltenden Zusammensetzungen zur Herstellung von Mitteln zur Beseitigung von oralem Malodor oder zur Verhinderung der Entstehung von oralem Malodor.1. Use of antioxidants or compositions containing antioxidants for the preparation of agents for eliminating oral malodor or for preventing the formation of oral malodor.
2. Verwendung nach Anspruch 1, dadurch gekennzeichnet, dass die Antioxidantien in Mengen von 0,001 - 30 Gew-.% (bezogen auf das Gesamtgewicht der Zubereitung) eingesetzt werden.2. Use according to claim 1, characterized in that the antioxidants are used in amounts of 0.001-30% by weight (based on the total weight of the preparation).
3. Verwendung nach einem der Ansprüche 1 oder 2, dadurch gekennzeichnet, dass die Antioxidantien in Mengen von 0,05 - 20 Gew-.% (Bezogen auf das Gesamtgewicht der Zubereitung) eingesetzt werden.3. Use according to one of claims 1 or 2, characterized in that the antioxidants are used in amounts of 0.05-20% by weight (based on the total weight of the preparation).
4. Verwendung nach einem der Ansprüche 1 bis 3, dadurch gekennzeichnet, dass die Antioxidantien in Mengen von 0,05 - 20 Gew-.% (bezogen auf das Gesamtgewicht der Zubereitung) eingesetzt werden.4. Use according to one of claims 1 to 3, characterized in that the antioxidants are used in amounts of 0.05-20% by weight (based on the total weight of the preparation).
5. Verwendung nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, dass die Antioxidantien in Mengen von 1 - 10 Gew-.% (bezogen auf das5. Use according to one of claims 1 to 4, characterized in that the antioxidants in amounts of 1-10% by weight (based on the
Gesamtgewicht der Zubereitung) eingesetzt werden.Total weight of the preparation).
6. Verwendung nach einem der Ansprüche 1 bis 5, dadurch gekennzeichnet, dass als Antioxidantien Vitamine und Coenzyme und Derivate dieser Stoffe angesetzt werden.6. Use according to one of claims 1 to 5, characterized in that vitamins and coenzymes and derivatives of these substances are used as antioxidants.
7. Verwendung nach einem der Ansprüche 1 bis 6, dadurch gekennzeichnet, dass als Antioxidantien Ubichinon und Ubichinol, Vitamin C, Vitamin A sowie Vitamin B und Derivate dieser Stoffe eingesetzt werden. 7. Use according to one of claims 1 to 6, characterized in that ubiquinone and ubiquinol, vitamin C, vitamin A and vitamin B and derivatives of these substances are used as antioxidants.
8. Verwendung nach einem der Ansprüche 1 bis 7, dadurch gekennzeichnet, dass Ubichinon 1-10, Ubichinol 1-10, Menachinon eingesetzt werden.8. Use according to one of claims 1 to 7, characterized in that ubiquinone 1-10, ubiquinol 1-10, menaquinone are used.
9. Verwendung nach einem der Ansprüche 1 bis 9, dadurch gekennzeichnet, dass Scorbylpalmitat, Mg - Ascorbylphosphat, Ascorbylacetat, Vitamin E - acetat, Vitamin A - palmitat, eingesetzt werden.9. Use according to any one of claims 1 to 9, characterized in that scorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate, vitamin E acetate, vitamin A palmitate are used.
10. Verwendung nach einem der Ansprüche 1 bis 9, dadurch gekennzeichnet, dass das Coenzym Q 10 eingesetzt wird.10. Use according to one of claims 1 to 9, characterized in that the coenzyme Q 10 is used.
11. Verwendung nach einem der Ansprüche 1 bis 10, dadurch gekennzeichnet, dass Ubichinon, Ubichinol, Vitamin B, Vitamin E, Vitamin A, Carotine, Carotinoide sowie die Derivate dieser Verbindungen in Mengen von 0,001 - 10 Gew-.% (bezogen auf das Gesamtgewicht der Zubereitung eingesetzt werden)11. Use according to one of claims 1 to 10, characterized in that ubiquinone, ubiquinol, vitamin B, vitamin E, vitamin A, carotenes, carotenoids and the derivatives of these compounds in amounts of 0.001-10% by weight (based on the Total weight of preparation used)
12. Verwendung nach einem der Ansprüche 1 bis 11, dadurch gekennzeichnet, dass Ubichinon, Ubichinol, Vitamin B, Vitamin E, Vitamin A, Carotine sowie die Derivate dieser Verbindungen in Mengen von 0,01 - 5 Gew-.% bezogen auf das Gesamtgewicht der Zubereitung eingesetzt werden.12. Use according to one of claims 1 to 11, characterized in that ubiquinone, ubiquinol, vitamin B, vitamin E, vitamin A, carotenes and the derivatives of these compounds in amounts of 0.01-5% by weight based on the total weight of the preparation.
13. Verwendung nach einem der Ansprüche 1 bis 12, dadurch gekennzeichnet, dass Ubichinon, Ubichinol, Vitamin B, Vitamin E, Vitamin A, Carotine sowie die Derivate dieser Verbindungen in Mengen von 0,1 - 2,5 Gew-.% bezogen auf das Gesamtgewicht der Zubereitung eingesetzt werden. 13. Use according to one of claims 1 to 12, characterized in that ubiquinone, ubiquinol, vitamin B, vitamin E, vitamin A, carotenes and the derivatives of these compounds in amounts of 0.1-2.5% by weight, based on the total weight of the preparation can be used.
EP01989563A 2000-12-15 2001-12-03 Use of antioxidants in means for treating halitosis Withdrawn EP1343461A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10062770 2000-12-15
DE10062770A DE10062770A1 (en) 2000-12-15 2000-12-15 Use of antioxidants for bad breath control agents
PCT/EP2001/014099 WO2002047637A1 (en) 2000-12-15 2001-12-03 Use of antioxidants in means for treating halitosis

Publications (1)

Publication Number Publication Date
EP1343461A1 true EP1343461A1 (en) 2003-09-17

Family

ID=7667427

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01989563A Withdrawn EP1343461A1 (en) 2000-12-15 2001-12-03 Use of antioxidants in means for treating halitosis

Country Status (5)

Country Link
US (1) US20040067204A1 (en)
EP (1) EP1343461A1 (en)
AU (1) AU2002227981A1 (en)
DE (1) DE10062770A1 (en)
WO (1) WO2002047637A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
DE102004043802A1 (en) * 2004-09-08 2006-03-09 Henkel Kgaa Mouth and dental care- and cleaning agent, useful for inflammatory diseases of the mouth and oral cavity e.g. gingivitis, comprises humectant and a protein of leguminous seeds e.g. protein of soy seeds
DE102004043945A1 (en) * 2004-09-11 2006-03-30 Henkel Kgaa Oral, dental and dental protease care products containing plaque-forming substances
DE102004061646A1 (en) * 2004-12-17 2006-07-20 S&C Polymer Silicon- und Composite-Spezialitäten GmbH Tooth bleaching
US20060134025A1 (en) * 2004-12-17 2006-06-22 Colgate-Palmolive Company Oral compositions containing extracts of Rosmarinus and related methods
BRPI0608691A2 (en) 2005-03-10 2010-12-07 3M Innovative Properties Co antimicrobial composition, and methods for killing or inactivating microorganisms in mammalian mucosal tissue, for treating an infected injury or wound, for decolonizing microorganisms, for providing residual antimicrobial efficacy on a surface, and for treating a condition
EP1858482B1 (en) 2005-03-10 2014-04-23 3M Innovative Properties Company Methods of reducing microbial contamination
EP1803802A1 (en) * 2005-12-30 2007-07-04 Maatschap F.J.R. Laugeman c.s. Cleansing composition
KR101480280B1 (en) * 2012-01-06 2015-01-14 주식회사 대웅제약 Composition comprising tauroursodeoxycholic acid
US9498421B2 (en) * 2012-12-19 2016-11-22 Colgate-Palmolive Company Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine
US20160228339A1 (en) 2013-09-18 2016-08-11 Glymur B.V. Oral hygiene compositions
US20170348213A1 (en) * 2014-12-24 2017-12-07 Colgate-Palmolive Company Oral Care Composition
US20190076343A1 (en) * 2017-09-14 2019-03-14 Gerald P. Curatola Oral care formulations and methods for use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE369036B (en) * 1972-06-30 1974-08-05 Astra Laekemedel Ab
WO1995007682A1 (en) * 1993-09-16 1995-03-23 Unilever N.V. Oral compositions containing stannous compounds
WO1996005803A1 (en) * 1994-08-22 1996-02-29 Quest International B.V. Breath malodour reduction
US5925335A (en) * 1997-06-12 1999-07-20 C.S. Bioscience Inc. Dental formulation
US5906811A (en) * 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US6200550B1 (en) * 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10
US6071500A (en) * 1999-01-19 2000-06-06 Thistle; Robert H. Breath spray with tooth decay and halitosis prevention characteristics
AU3288900A (en) * 1999-04-16 2000-11-02 Unilever Plc Breath freshening lipstick comprising menthol
US6231836B1 (en) * 1999-07-12 2001-05-15 Robert Takhtalian Folic acid dentifrice
CN1367663A (en) * 1999-09-08 2002-09-04 Amt技术公司 Ocular biometer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0247637A1 *

Also Published As

Publication number Publication date
DE10062770A1 (en) 2002-07-25
WO2002047637A1 (en) 2002-06-20
US20040067204A1 (en) 2004-04-08
AU2002227981A1 (en) 2002-06-24

Similar Documents

Publication Publication Date Title
US8956592B2 (en) Oral care compositions
US9801940B2 (en) Oral care compositions
EP1343461A1 (en) Use of antioxidants in means for treating halitosis
DE60314887T2 (en) COMPOSITION FOR DEPIGMENTING THE SKIN CONTAINING ADAPAL AND AT LEAST ONE DEPIGMENTING AGENT
DE69506119T2 (en) ORAL COMPOSITIONS
WO2016104536A1 (en) Method for producing liquid composition for oral cavity and liquid composition for oral cavity
EP1049454B1 (en) Cosmetic and dermatological preparations containing higher electrolyte concentrations
JP5589849B2 (en) Dentifrice composition
DE60221989T2 (en) ORAL PRODUCTS CONTAIN A FLUOR-ION VECTOR AND ANTIOXIDANT
EP2192891B1 (en) Material composition for oral hygiene product
US20120034312A1 (en) 4-isopropyl-3-methylphenol for the treatment of inflammation
JPH04182419A (en) Composition for oral cavity use
DE69119588T2 (en) USE OF KETOROLAC FOR THE TREATMENT OF PERIODONTITIS
EP0884048B1 (en) Cosmetic and dermatological emulsions containing alkylglucosides and increased electrolyte concentrations
JPS6388117A (en) Composition for oral cavity
JP2006248953A (en) Wrinkle ameliorating agent and external composition for skin
KR101142445B1 (en) Tooth Paste Composition Containing Argan Oil
AU2021394866B2 (en) Oral care compositions with a natural sweetener system
ES2897401T3 (en) Composition comprising an antiseptic, a neutralizer of volatile sulfur compounds and an anticariogenic agent
WO2002053148A1 (en) Ubiquinone derivatives containing dental care agents
JP2010024176A (en) Wrinkle-improving agent
DE102016203146A1 (en) Antibacterial oral care gels
CN113456546A (en) Oral care solution
JP2009040719A (en) Cosmetic composition
JP2003113082A (en) Composition for oral hygiene

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030715

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050630